Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Giséle Lagathu

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected With HCV Genotypes 1–5

Antiviral Therapy

Infectious Diseases

Pharmacology

2011

English

Related publications

Distribution of Natural Resistance to NS3 Protease Inhibitors in Hepatitis C Genotype 1a Separated Into Clades 1 and 2 and in Genotype 1b of HIV-infected Patients

Clinical Microbiology and Infection

English

Physical Properties and Biological Activity of Some Novel HCV NS3 Protease Inhibitors

Egyptian Journal of Physics

2018

English

Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method to Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes From HCV Genotypes 1 to 6

English

Naturally Occurring Mutations to HCV Protease Inhibitors in Treatment-Naïve Patients

English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology

Virology

Infectious Diseases

2012

English

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Journal of Clinical Microbiology

Microbiology

1999

English

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2020

English

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2005

English

Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations Following Treatment in Chronic HCV Genotype 1-Infected Individuals

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Giséle Lagathu

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected With HCV Genotypes 1–5

Related publications

Distribution of Natural Resistance to NS3 Protease Inhibitors in Hepatitis C Genotype 1a Separated Into Clades 1 and 2 and in Genotype 1b of HIV-infected Patients

Physical Properties and Biological Activity of Some Novel HCV NS3 Protease Inhibitors

Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method to Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes From HCV Genotypes 1 to 6

Naturally Occurring Mutations to HCV Protease Inhibitors in Treatment-Naïve Patients

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations Following Treatment in Chronic HCV Genotype 1-Infected Individuals